// App-Quantinova.ai

TCT-35 : One-Month Dual Antiplatelet Therapy After PCI With Resolute Onyx DES: Final 2-Year Results From Onyx ONE Clear

Researchers

Presenter

  • David Kandzari

Principal Investigators

  • Ajay Kirtane

  • Roxana Mehran

  • Matthew Price

  • Daniel Simon

  • Azeem Latib

  • Elvin Kedhi

  • Alexandre Abizaid

  • Stephen G. Worthley

  • Azfar Zaman

  • Maria Parke

  • Amanda Mahoney

  • Te-Hsin Lung

  • Stephan Windecker

  • Gregg Stone

Medical Centers

  • Icahn School Of Medicine, New York, New York, USA

  • Medtronic, San Jose, California, USA

  • University Hospitals Case Medical Center, Cleveland, Ohio, USA

  • Medtronic, Forest Lake, Minnesota, USA

  • Erasme Hospital Universite Libre de Bruxelles, Brussels, Netherlands

  • Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil

  • Scripps Clinic, La Jolla, California, USA

  • Genesis Healthcare, Sydney, Victoria, Australia

  • Piedmont Heart Institute, Atlanta, Georgia, USA

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Swiss Cardiovascular Center Bern, Bern, Switzerland

  • Montefiore Medical Center, Scarsdale, New York, USA

  • Cardiovascular Research Foundation, New York, New York, USA

  • New York-Presbyterian/Columbia University Medical Center, New York, New York, USA

Locations

  • United States

  • Australia

  • United Kingdom

  • Switzerland

  • Netherlands

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved